1. Home
  2. EVTL vs DTIL Comparison

EVTL vs DTIL Comparison

Compare EVTL & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertical Aerospace Ltd.

EVTL

Vertical Aerospace Ltd.

HOLD

Current Price

$0.90

Market Cap

235.6M

Sector

Industrials

ML Signal

HOLD

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

HOLD

Current Price

$7.47

Market Cap

214.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTL
DTIL
Founded
2016
2006
Country
United Kingdom
United States
Employees
454
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
235.6M
214.7M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
EVTL
DTIL
Price
$0.90
$7.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
2
Target Price
$12.70
$45.00
AVG Volume (30 Days)
2.2M
307.2K
Earning Date
03-24-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,070,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.19
$3.53
52 Week High
$7.35
$9.62

Technical Indicators

Market Signals
Indicator
EVTL
DTIL
Relative Strength Index (RSI) 28.49 49.84
Support Level N/A $6.62
Resistance Level $1.79 $7.96
Average True Range (ATR) 0.13 0.42
MACD -0.01 0.00
Stochastic Oscillator 12.83 72.17

Price Performance

Historical Comparison
EVTL
DTIL

About EVTL Vertical Aerospace Ltd.

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero-emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Share on Social Networks: